Atrium Therapeutics raises capital
- Sold 5,170,384 shares of common stock
- Issued pre-funded warrants for 1,134,930 shares
- Post-offering shares outstanding: 21,571,507
RNA
Atrium Therapeutics, Inc. SEC filings
Every EDGAR filing for Atrium Therapeutics, Inc. (RNA), newest first, with AI summaries and stories.
- Ticker
- RNA
- CIK
- 2093101
- Sector
- Biotech and pharma
- Latest filing
- Oct 9
Next: earnings expected ~May 14 · 10-Q expected ~May 14 (deadline May 17)
Insider activity
No open-market insider buys in the last 30 days.
Also: 8 grants or exercises.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-K/AAtrium Therapeutics, Inc.RNALIVE ROUTINE8-KAtrium Therapeutics, Inc.RNALIVE Atrium Therapeutics raises $50M
- Closed on Oct 9, 2026
- Sold 5,170,384 shares at $7.93
- Pre-funded warrants for 1,134,930 shares
ROUTINE4Atrium Therapeutics, Inc.RNALIVE 8 insider filings
Husam Younis, insider filing for RNA
Show all 8
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
Husam Younis, reporting
ROUTINESCHEDULE 13G/AAtrium Therapeutics, Inc.RNALIVE 2 13G filings
Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13GOwnership stake disclosure
RA CAPITAL MANAGEMENT, L.P., filed by
ROUTINESCHEDULE 13G/AAtrium Therapeutics, Inc.RNALIVE Ownership stake disclosure by PRICE T ROWE ASSOCIATES INC /MD/ (amended)
PRICE T ROWE ASSOCIATES INC /MD/, filed by
NOTABLE10-QAtrium Therapeutics, Inc.RNALIVE ROUTINE8-KAtrium Therapeutics, Inc.RNALIVE ROUTINESCHEDULE 13G/AAtrium Therapeutics, Inc.RNALIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINE8-KAtrium Therapeutics, Inc.RNALIVE ROUTINESCHEDULE 13G/AAvidity Biosciences, Inc.RNAMLIVE Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)
RA CAPITAL MANAGEMENT, L.P., filed by
ROUTINESCHEDULE 13GAtrium Therapeutics, Inc.RNALIVE Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P., filed by
NOTABLE10-QAtrium Therapeutics, Inc.RNALIVE ROUTINE8-KAtrium Therapeutics, Inc.RNALIVE ROUTINESCHEDULE 13GAtrium Therapeutics, Inc.RNALIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
ROUTINE4Atrium Therapeutics, Inc.RNALIVE 6 insider filings
Stephanie Kenney, insider filing for RNA
Show all 6
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
Stephanie Kenney, reporting
ROUTINES-8Atrium Therapeutics, Inc.RNALIVE ROUTINESCHEDULE 13GAtrium Therapeutics, Inc.RNALIVE Ownership stake disclosure by PRICE T ROWE ASSOCIATES INC /MD/
PRICE T ROWE ASSOCIATES INC /MD/, filed by
ROUTINE15-12GAvidity Biosciences, Inc.RNAMLIVE ROUTINE4Atrium Therapeutics, Inc.LIVE 5 insider filings
Sarah Boyce, insider filing for Atrium Therapeutics, Inc.
Show all 5
- 4Insider filing for Atrium Therapeutics, Inc.
- 4Insider filing for Atrium Therapeutics, Inc.
- 4Insider filing for Atrium Therapeutics, Inc.
- 4Insider filing for Atrium Therapeutics, Inc.
- 4Insider filing for Atrium Therapeutics, Inc.
Sarah Boyce, reporting
ROUTINE8-KAtrium Therapeutics, Inc.LIVE ROUTINE4Avidity Biosciences, Inc.RNALIVE 13 insider filings
Teresa McCarthy, insider filing for RNA
Show all 13
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
- 4Insider filing for RNA
Teresa McCarthy, reporting